We are live on ! Find out more
MYOV

Myovant Sciences Ltd.

Delisted

MYOV was delisted on the 9th of March, 2023.

89 hedge funds and large institutions have $400M invested in Myovant Sciences Ltd. in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 28

16% less capital invested

Capital invested by funds: $475M → $400M (-$75.2M)

19% less funds holding

Funds holding: 11089 (-21)

38% less call options, than puts

Call options by funds: $5.52M | Put options by funds: $8.91M

61% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 33

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
89
Holders Change
-21
Holders Change %
-19.09%
% of All Funds
1.4%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
28
Reduced
28
Closed
33
Calls
$5.52M
Puts
$8.91M
Net Calls
-$3.4M
Net Calls Change
+$3.12M
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$1.58M -$570K -42,535 -26%
AA
27
ALPS Advisors
Colorado
$1.28M -$154K -11,477 -11%
Northern Trust
28
Northern Trust
Illinois
$1.22M -$22.1K -1,646 -2%
Swiss National Bank
29
Swiss National Bank
Switzerland
$1.18M +$97.9K +7,300 +9%
ACM
30
ACT Capital Management
Pennsylvania
$1.13M
TIP
31
Torray Investment Partners
Maryland
$1.06M +$334K +24,889 +45%
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$966K -$186K -13,870 -16%
CAPTRUST Financial Advisors
33
CAPTRUST Financial Advisors
North Carolina
$936K +$1.34K +100 +0.1%
Rockefeller Capital Management
34
Rockefeller Capital Management
New York
$892K +$228K +17,000 +34%
Millennium Management
35
Millennium Management
New York
$853K -$727K -54,251 -46%
LBA
36
Letko, Brosseau & Associates
Quebec, Canada
$842K
DA
37
Duality Advisers
Florida
$721K +$726K +54,164 New
Jane Street
38
Jane Street
New York
$672K -$124K -9,276 -16%
RCAP
39
Resolute Capital Asset Partners
Colorado
$666K +$670K +50,000 New
Citigroup
40
Citigroup
New York
$616K -$1.92M -143,022 -76%
ACA
41
Apis Capital Advisors
New York
$533K +$536K +40,000 New
Barclays
42
Barclays
United Kingdom
$495K +$498K +37,172 New
Cambridge Investment Research Advisors
43
Cambridge Investment Research Advisors
Iowa
$474K -$16.1K -1,200 -3%
CSS
44
Cubist Systematic Strategies
Connecticut
$466K +$186K +13,835 +65%
Group One Trading
45
Group One Trading
Illinois
$462K +$156K +11,625 +50%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$434K +$19.4K +1,450 +5%
UBS AM
47
UBS AM
Illinois
$432K
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$413K +$416K +31,000 New
Legal & General Group
49
Legal & General Group
United Kingdom
$373K +$7.94K +592 +2%
Bank of New York Mellon
50
Bank of New York Mellon
New York
$354K

MYOV Hedge Fund Activity: Q1 2022 in Review

89 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2022, worth a combined $400M — down 16% from $475M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of MYOV and 13 opened new positions — a net loss of 20 holders — while 28 trimmed existing stakes and 28 added.

The largest buyer was State Street, adding an estimated $6.23M. The largest seller was Bellevue Group, cutting an estimated $4.16M.

  • 89 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2022, down from 110 in Q4 2021.
  • Funds reported $400M of Myovant Sciences Ltd. stock for Q1 2022, down 16% quarter-over-quarter.
  • 13 funds opened new Myovant Sciences Ltd. positions in Q1 2022 and 33 closed out, a net change of -20 holders.
  • The largest Myovant Sciences Ltd. buyer in Q1 2022 was State Street, an estimated $6.23M added.
  • The largest Myovant Sciences Ltd. seller in Q1 2022 was Bellevue Group, an estimated $4.16M sold.

Based on aggregated 13F filings for Q1 2022.